Eco Animal Health gets regulatory nod for pig respiratory disease treatment

Fri, 22nd May 2020

Animal drug company Eco Animal Health said it had received a positive opinion from the European Medicines Agency for the use of Aivlosin water-soluble granules for the treatment of Mycoplasma hyopneumoniae in pigs. Mycoplasma hyopneumoniae was the most common primary pathogen in pig respiratory disease and a key instigator of secondary bacterial and viral pathogens. Aivlosin, an antimicrobial, was used under veterinary prescription for the treatment of a variety of economically important respiratory and enteric diseases in poultry and pigs. The European Commission as expected to issue a marketing authorisation within two months of the publication of a positive opinion, the company said. At 1:27pm: (LON:EAH) Eco Animal Health Group PLC share price was +10.5p at 208p Story provided by

FTSE 100 Latest